These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 2487530
1. Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique). Thormann J, Kramer W, Kremer P, Schlepper M. Cardiovasc Drugs Ther; 1989 Apr; 3(2):145-54. PubMed ID: 2487530 [Abstract] [Full Text] [Related]
2. Do class 1 antiarrhythmic drugs impair myocardial contractility? The class 1A example of ajmaline (conductance catheter technique). Thormann J, Hüting J, Kremer P, Wissemann J, Bahawar H, Schlepper M. J Cardiovasc Pharmacol; 1990 Aug; 16(2):182-90. PubMed ID: 1697372 [Abstract] [Full Text] [Related]
3. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone]. Gülker H, Heuer H, Thale J, Behrenbeck T. Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162 [Abstract] [Full Text] [Related]
4. Assessment of the antiarrhythmic profile of the new class I agent diprafenone. Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F. Arzneimittelforschung; 1985 Jul; 35(9):1387-93. PubMed ID: 4084340 [Abstract] [Full Text] [Related]
5. [Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique)]. Thormann J, Hüting J, Kremer P, Mitrovic V, Wissemann J, Bahawar H, Schlepper M. Z Kardiol; 1990 Oct; 79(10):706-16. PubMed ID: 2087858 [Abstract] [Full Text] [Related]
6. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H. Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720 [Abstract] [Full Text] [Related]
7. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol. Greenberg S, Cantor E, Paul J. J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625 [Abstract] [Full Text] [Related]
8. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man. Wagner F, Jähnchen E, Trenk D. Eur J Clin Pharmacol; 1989 Sep; 36(6):579-82. PubMed ID: 2570700 [Abstract] [Full Text] [Related]
9. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart. Groschner K, Lindner W, Schnedl H, Kukovetz WR. Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837 [Abstract] [Full Text] [Related]
10. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction. Lotto A, Finzi A, Massari FM, Pagnoni F, Valentini R, Ambrosini F, Lo Masto M. G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385 [Abstract] [Full Text] [Related]
11. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease]. Thormann J, Mitrovic V, Strasser R, Pitschner HF, Riedel H, Bahavar H, Schlepper M. Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715 [Abstract] [Full Text] [Related]
13. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone. Kohlhardt M, Fichtner H. J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471 [Abstract] [Full Text] [Related]
14. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers. Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H. J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253 [Abstract] [Full Text] [Related]
15. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man. Trenk D, Wagner F, Sachs W, Jähnchen E. Eur J Clin Pharmacol; 1989 Jul; 37(3):313-6. PubMed ID: 2612546 [Abstract] [Full Text] [Related]
16. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells. Kodama I, Suzuki R, Honjo H, Toyama J. Br J Pharmacol; 1992 Nov; 107(3):813-20. PubMed ID: 1335340 [Abstract] [Full Text] [Related]
17. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Manz M, Beermann J, Gerckens U, Lüderitz B. Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226 [Abstract] [Full Text] [Related]
18. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels. Kohlhardt M, Fichtner H. Eur J Pharmacol; 1988 Oct 26; 156(1):55-62. PubMed ID: 2850211 [Abstract] [Full Text] [Related]
19. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Circulation; 1985 May 26; 71(5):889-900. PubMed ID: 3986979 [Abstract] [Full Text] [Related]
20. Diprafenone for treatment of Wolff-Parkinson-White syndrome. Kunze KP, Schlüter M, Geiger M, Kuck KH. Cardiovasc Drugs Ther; 1989 Mar 26; 3(1):73-9. PubMed ID: 2487525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]